Charles River, Aitia collaborate on AI-powered drug discovery solution
Under the agreement, Aitia will deploy Charles River's Logica across its portfolio of novel drug targets to optimise…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Nov 23
Under the agreement, Aitia will deploy Charles River's Logica across its portfolio of novel drug targets to optimise…
10 Nov 23
The partnership will combine Recursion’s artificial intelligence (AI)-guided drug discovery platform with Bayer’s small molecule compound library and…
09 Nov 23
The goal is to harness the power of large-scale life science models, accelerating the design of AAV vectors,…
08 Nov 23
Under the partnership, both firms will advance the oncology pipeline of condensate modifying therapeutics to Investigational New Drug…
07 Nov 23
Genevant’s collaboration with Novo Nordisk builds upon a joint research and development collaboration in hemophilia A between Novo…
03 Nov 23
The data showed one of Maxwell's Claromer compounds is active against Ebola virus within the critical time frame…
02 Nov 23
Under the terms of the agreement, AstraZeneca will use Cellectis’ patented gene editing technologies and manufacturing expertise to…
02 Nov 23
The multi-year collaboration agreement is intended to discover and develop chimeric antigen receptor (CAR) T-cell therapies and armouring…
02 Nov 23
Multi-year collaboration to jointly discover, develop, and commercialize novel oncology medicines for up to five programs, with the…
31 Oct 23
Agreement represents strong strategic fit that leverages the company’s internal DNA damage response expertise and in-house ADC capabilities